Form 4: NeuroPace Director R Scott Huennekens Acquires 15,507 Stock Options
SEC Form 4 Filing
R Scott Huennekens, a director of NeuroPace Inc, acquired 15,507 stock options on January 6, 2025.
Summary
- On January 6, 2025, R Scott Huennekens, a director at NeuroPace Inc, acquired 15,507 stock options.
- The exercise price of these options is $11.93.
- The options vest in 36 equal monthly installments.
- The expiration date for these options is January 5, 2035.
- Following the transaction, Huennekens directly owns 15,507 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting a standard stock option grant to a company director. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This is a standard SEC Form 4 filing, indicating a change in beneficial ownership of securities by a company insider. It's a routine part of corporate governance and transparency.
Stakeholder Impact
- The acquisition of stock options by a director could align their interests with those of shareholders, potentially encouraging decisions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 01/06/2025 | Date of transaction: R Scott Huennekens acquired stock options. |
| 01/08/2025 | Date of signature: Leah Akin, Attorney-in-Fact, signed the document. |
| 01/05/2035 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.